Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Durgam

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
International Clinical Psychopharmacology|July 11, 2017
Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studiesWillie Earley, Suresh Durgam, Kaifeng Lu, et al.
The Journal of Clinical Psychiatry|April 27, 2023
The Efficacy of Lumateperone in Patients With Bipolar Depression With Mixed FeaturesRoger S McIntyre, Suresh Durgam, Jason Huo, et al.
The Primary Care Companion for CNS Disorders|August 4, 2016
Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With VilazodoneArif Khan, Suresh Durgam, Xiongwen Tang, et al.
CNS Spectrums|May 20, 2017
Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorderMichael E Thase, Carl Gommoll, Changzheng Chen, et al.
Journal of Affective Disorders|February 25, 2026
The efficacy of lumateperone across symptoms of a major depressive episode with mixed features in patients with major depressive disorder and bipolar disorder: Post hoc analysesLakshmi N Yatham, Susan G Kozauer, Willie R Earley, et al.
International Clinical Psychopharmacology|July 26, 2018
Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trialMaurizio Fava, Suresh Durgam, Willie Earley, et al.
Schizophrenia Research|January 14, 2014
An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trialSuresh Durgam, Anju Starace, Dayong Li, et al.
Neuropsychiatric Disease and Treatment|August 18, 2017
Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension studySuresh Durgam, Ronald P Landbloom, Mary Mackle, et al.
Bipolar Disorders|July 25, 2014
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trialSuresh Durgam, Anju Starace, Dayong Li, et al.
International Clinical Psychopharmacology|August 21, 2015
Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose studyCarl Gommoll, Giovanna Forero, Maju Mathews, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
International Clinical Psychopharmacology|July 11, 2017
Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studiesWillie Earley, Suresh Durgam, Kaifeng Lu, et al.
The Journal of Clinical Psychiatry|April 27, 2023
The Efficacy of Lumateperone in Patients With Bipolar Depression With Mixed FeaturesRoger S McIntyre, Suresh Durgam, Jason Huo, et al.
The Primary Care Companion for CNS Disorders|August 4, 2016
Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With VilazodoneArif Khan, Suresh Durgam, Xiongwen Tang, et al.
CNS Spectrums|May 20, 2017
Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorderMichael E Thase, Carl Gommoll, Changzheng Chen, et al.
Journal of Affective Disorders|February 25, 2026
The efficacy of lumateperone across symptoms of a major depressive episode with mixed features in patients with major depressive disorder and bipolar disorder: Post hoc analysesLakshmi N Yatham, Susan G Kozauer, Willie R Earley, et al.
International Clinical Psychopharmacology|July 26, 2018
Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trialMaurizio Fava, Suresh Durgam, Willie Earley, et al.
Schizophrenia Research|January 14, 2014
An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trialSuresh Durgam, Anju Starace, Dayong Li, et al.
Neuropsychiatric Disease and Treatment|August 18, 2017
Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension studySuresh Durgam, Ronald P Landbloom, Mary Mackle, et al.
Bipolar Disorders|July 25, 2014
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trialSuresh Durgam, Anju Starace, Dayong Li, et al.
International Clinical Psychopharmacology|August 21, 2015
Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose studyCarl Gommoll, Giovanna Forero, Maju Mathews, et al.
Pageof 6